# Daito Pharmaceutical Co., Ltd. – FDA Inspection, Dec 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/daito-pharmaceutical-co-ltd/f70a2428-1ef7-45a6-abe8-c8a8e761bbab
Source feed: FDA_Inspections

> FDA inspection 1226666 of Daito Pharmaceutical Co., Ltd., December 19, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226666
- Company Name: Daito Pharmaceutical Co., Ltd.
- Inspection Date: 2023-12-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1180850 - 2022-09-16
- [FDA Inspection 1037107 - 2017-11-10](https://www.keypedia.com/records/fda_inspections/daito-pharmaceutical-co-ltd/b2ca8f6e-e975-4d14-96d8-5a032a43ddd6)
- FDA Inspection 748400 - 2011-09-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/daito-pharmaceutical-co-ltd/3a27bbaf-60c1-44b3-acf3-48f8935483e8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c